These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia. Hoffer MJ, Snieder H, Bredie SJ, Demacker PN, Kastelein JJ, Frants RR, Stalenhoef AF. Atherosclerosis; 2000 Aug; 151(2):443-50. PubMed ID: 10924721 [Abstract] [Full Text] [Related]
3. Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia. de Bruin TW, Mailly F, van Barlingen HH, Fisher R, Castro Cabezas M, Talmud P, Dallinga-Thie GM, Humphries SE. Eur J Clin Invest; 1996 Aug; 26(8):631-9. PubMed ID: 8872057 [Abstract] [Full Text] [Related]
4. Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach. Minicocci I, Prisco C, Montali A, Di Costanzo A, Ceci F, Pigna G, Arca M. Atherosclerosis; 2015 Oct; 242(2):618-24. PubMed ID: 26342331 [Abstract] [Full Text] [Related]
5. Gender-related association between the -93T-->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia. Hoffer MJ, Bredie SJ, Snieder H, Reymer PW, Demacker PN, Havekes LM, Boomsma DI, Stalenhoef AF, Frants RR, Kastelein JJ. Atherosclerosis; 1998 May; 138(1):91-9. PubMed ID: 9678774 [Abstract] [Full Text] [Related]
6. Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity. Deeb SS, Nevin DN, Iwasaki L, Brunzell JD. Hum Mutat; 1996 May; 8(4):319-25. PubMed ID: 8956036 [Abstract] [Full Text] [Related]
8. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Yang WS, Nevin DN, Peng R, Brunzell JD, Deeb SS. Proc Natl Acad Sci U S A; 1995 May 09; 92(10):4462-6. PubMed ID: 7753827 [Abstract] [Full Text] [Related]
10. Lipoprotein lipase gene mutations in coronary artery disease. Minnich A, Baloukas J, Roederer G, Lussier-Cacan S, Davignon J, Genest J. Can J Cardiol; 1998 May 09; 14(5):711-6. PubMed ID: 9627528 [Abstract] [Full Text] [Related]
11. Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia. Campagna F, Montali A, Baroni MG, Maria AT, Ricci G, Antonini R, Verna R, Arca M. Metabolism; 2002 Oct 09; 51(10):1298-305. PubMed ID: 12370850 [Abstract] [Full Text] [Related]
12. Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Nordestgaard BG, Abildgaard S, Wittrup HH, Steffensen R, Jensen G, Tybjaerg-Hansen A. Circulation; 1997 Sep 16; 96(6):1737-44. PubMed ID: 9323055 [Abstract] [Full Text] [Related]
13. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. Groenemeijer BE, Hallman MD, Reymer PW, Gagné E, Kuivenhoven JA, Bruin T, Jansen H, Lie KI, Bruschke AV, Boerwinkle E, Hayden MR, Kastelein JJ. Circulation; 1997 Jun 17; 95(12):2628-35. PubMed ID: 9193431 [Abstract] [Full Text] [Related]
14. Familial combined hyperlipidemia and abnormal lipoprotein lipase. Babirak SP, Brown BG, Brunzell JD. Arterioscler Thromb; 1992 Oct 17; 12(10):1176-83. PubMed ID: 1390589 [Abstract] [Full Text] [Related]
16. LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins. Vakkilainen J, Jauhiainen M, Ylitalo K, Nuotio IO, Viikari JS, Ehnholm C, Taskinen MR. J Lipid Res; 2002 Apr 17; 43(4):598-603. PubMed ID: 11907142 [Abstract] [Full Text] [Related]
17. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Reymer PW, Groenemeyer BE, Gagné E, Miao L, Appelman EE, Seidel JC, Kromhout D, Bijvoet SM, van de Oever K, Bruin T. Hum Mol Genet; 1995 Sep 17; 4(9):1543-9. PubMed ID: 8541837 [Abstract] [Full Text] [Related]
18. Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia. Gagné E, Genest J, Zhang H, Clarke LA, Hayden MR. Arterioscler Thromb; 1994 Aug 17; 14(8):1250-7. PubMed ID: 8049185 [Abstract] [Full Text] [Related]
19. A novel variant in LPL gene is associated with familial combined hyperlipidemia. Taghizadeh E, Ghayour-Mobarhan M, Ferns GA, Pasdar A. Biofactors; 2020 Jan 17; 46(1):94-99. PubMed ID: 31599081 [Abstract] [Full Text] [Related]
20. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia. Nohara A, Kawashiri MA, Claudel T, Mizuno M, Tsuchida M, Takata M, Katsuda S, Miwa K, Inazu A, Kuipers F, Kobayashi J, Koizumi J, Yamagishi M, Mabuchi H. Arterioscler Thromb Vasc Biol; 2007 Apr 17; 27(4):923-8. PubMed ID: 17272748 [Abstract] [Full Text] [Related] Page: [Next] [New Search]